Marex Group’s Mesoblast MESO Stock Holding History

Marex Group’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100,000	Closed	-$1.09M	–	953
2025 Q2	$1.09M	Buy	+100,000	New	+$1.12M	0.01%	279

Other funds holding MESO

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Marex Group's MESO Position: Q3 2025 in Review

Marex Group sold out of Mesoblast (MESO) in Q3 2025, closing a stake of 100,000 shares — an estimated $1.09M sold.

Marex Group first reported a position in MESO in Q1 2025 and held it in 2 quarters. The position peaked at $1.25M in Q1 2025. 68 funds tracked by Wall St. Rank hold MESO as of Q3 2025.

Marex Group reported no remaining Mesoblast position as of Q3 2025 after selling out during the quarter.
Marex Group sold 100,000 Mesoblast shares in Q3 2025, an estimated $1.09M.
Marex Group first reported a position in Mesoblast in Q1 2025 and held it in 2 quarters.
Marex Group's Mesoblast position peaked at $1.25M in Q1 2025.
68 funds tracked by Wall St. Rank held Mesoblast as of Q3 2025.

Based on Marex Group's 13F filing for Q3 2025, filed 14 Nov 2025.